Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 2
2006 1
2007 2
2009 3
2010 3
2011 3
2014 2
2016 2
2017 2
2018 6
2019 4
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
Nilotinib in the treatment of chronic myeloid leukemia.
Sacha T, Saglio G. Sacha T, et al. Future Oncol. 2019 Mar;15(9):953-965. doi: 10.2217/fon-2018-0468. Epub 2018 Dec 14. Future Oncol. 2019. PMID: 30547682 Review.
Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Single-Group, Phase 2, Open-Label Study.
Mahon FX, Boquimpani C, Kim DW, Benyamini N, Clementino NCD, Shuvaev V, Ailawadhi S, Lipton JH, Turkina AG, De Paz R, Moiraghi B, Nicolini FE, Dengler J, Sacha T, Takahashi N, Fellague-Chebra R, Acharya S, Wong S, Jin Y, Hughes TP. Mahon FX, et al. Among authors: sacha t. Ann Intern Med. 2018 Apr 3;168(7):461-470. doi: 10.7326/M17-1094. Epub 2018 Feb 20. Ann Intern Med. 2018. PMID: 29459949 Clinical Trial.
A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs.
Link-Lenczowska D, Pallisgaard N, Cordua S, Zawada M, Czekalska S, Krochmalczyk D, Kanduła Z, Sacha T. Link-Lenczowska D, et al. Among authors: sacha t. Ann Hematol. 2018 Dec;97(12):2299-2308. doi: 10.1007/s00277-018-3451-1. Epub 2018 Jul 28. Ann Hematol. 2018. PMID: 30056580 Free PMC article. Clinical Trial.
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin.
Lauseker M, Bachl K, Turkina A, Faber E, Prejzner W, Olsson-Strömberg U, Baccarani M, Lomaia E, Zackova D, Ossenkoppele G, Griskevicius L, Schubert-Fritschle G, Sacha T, Heibl S, Koskenvesa P, Bogdanovic A, Clark RE, Guilhot J, Hoffmann VS, Hasford J, Hochhaus A, Pfirrmann M. Lauseker M, et al. Among authors: sacha t. Am J Hematol. 2019 Nov;94(11):1236-1243. doi: 10.1002/ajh.25628. Epub 2019 Sep 14. Am J Hematol. 2019. PMID: 31456269
Quantitative measurement of selected protein biomarkers of endothelial dysfunction in plasma by micro-liquid chromatography-tandem mass spectrometry based on stable isotope dilution method.
Suraj J, Kurpińska A, Sternak M, Smolik M, Niedzielska-Andres E, Zakrzewska A, Sacha T, Kania A, Chlopicki S, Walczak M. Suraj J, et al. Among authors: sacha t. Talanta. 2019 Mar 1;194:1005-1016. doi: 10.1016/j.talanta.2018.10.067. Epub 2018 Oct 23. Talanta. 2019. PMID: 30609507
Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
Al-Ali HK, Griesshammer M, Foltz L, Palumbo GA, Martino B, Palandri F, Liberati AM, le Coutre P, García-Hernández C, Zaritskey A, Tavares R, Gupta V, Raanani P, Giraldo P, Hänel M, Damiani D, Sacha T, Bouard C, Paley C, Tiwari R, Mannelli F, Vannucchi AM. Al-Ali HK, et al. Among authors: sacha t. Br J Haematol. 2020 Jun;189(5):888-903. doi: 10.1111/bjh.16462. Epub 2020 Feb 4. Br J Haematol. 2020. PMID: 32017044
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.
Racil Z, Koritakova E, Sacha T, Klamova H, Belohlavkova P, Faber E, Rea D, Malaskova L, Prochazkova J, Zackova D, Voglova J, Wącław J, Cetkovsky P, Zak P, Mayer J. Racil Z, et al. Among authors: sacha t. Am J Hematol. 2018 Oct;93(10):E342-E345. doi: 10.1002/ajh.25232. Epub 2018 Aug 31. Am J Hematol. 2018. PMID: 30054949 Free article. Clinical Trial. No abstract available.
Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis: A Retrospective Analysis of 527 Patients From the Polish Adult Leukemia Group Registry.
Gora-Tybor J, Sacha T, Wącław J, Niesiobędzka-Krężel J, Grzybowska-Izydorczyk O, Mędraś E, Dereń-Wagemann I, Patkowska E, Seferyńska I, Lewandowski K, Wache A, Blajer-Olszewska B, Wątek M, Kotwica-Mojzych K, Wasilewska E, Warzocha K, Jamroziak K. Gora-Tybor J, et al. Among authors: sacha t. Clin Lymphoma Myeloma Leuk. 2018 Jul;18(7):e283-e285. doi: 10.1016/j.clml.2018.05.001. Epub 2018 May 9. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29778693 No abstract available.
Imatinib in chronic myeloid leukemia: an overview.
Sacha T. Sacha T. Mediterr J Hematol Infect Dis. 2014 Jan 2;6(1):e2014007. doi: 10.4084/MJHID.2014.007. eCollection 2014 Jan 2. Mediterr J Hematol Infect Dis. 2014. PMID: 24455116 Free PMC article. Review.
Comparison of health locus of control in oncological and non-oncological patients.
Gibek K, Sacha T. Gibek K, et al. Among authors: sacha t. Contemp Oncol (Pozn). 2019;23(2):115-120. doi: 10.5114/wo.2019.85638. Epub 2019 May 31. Contemp Oncol (Pozn). 2019. PMID: 31316295 Free PMC article.
36 results
Jump to page
Feedback